CLINICAL TRIALS PROFILE FOR ENTECAVIR
✉ Email this page to a colleague
All Clinical Trials for entecavir
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00035633 ↗ | A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen | Completed | Bristol-Myers Squibb | Phase 3 | 2001-12-01 | The purpose of this clinical research study is to assess the safety effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen positive. |
NCT00035789 ↗ | A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen | Completed | Bristol-Myers Squibb | Phase 3 | 2001-11-01 | The purpose of this clinical research study is to assess the safety and effectiveness of entecavir, as compared to lamivudine, in the treatment of adults with chronic hepatitis B infection who are hepatitis B e antigen negative. |
NCT00036608 ↗ | A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine | Completed | Bristol-Myers Squibb | Phase 3 | 2002-01-01 | The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for entecavir
Condition Name
Clinical Trial Locations for entecavir
Trials by Country
Clinical Trial Progress for entecavir
Clinical Trial Phase
Clinical Trial Sponsors for entecavir
Sponsor Name